Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guided Therapeutics - GTHP -- Ignore unavailable to you. Want to Upgrade?

To: Robin who wrote (30)	8/28/1998 10:35:00 AM
From: BitWizrd	Read Replies (1) \| Respond to of 118

>>>Mr. Wizard, <<< Call me Bit, please. I'm not so smart as to have earned that moniker :). >>>If IR doesn't work, I don't see much impact on SPRX other than reducing the competition they face. <<< My mistake. I was under the impression that SPRX relies on FIR. Please educate me. I do not have a position, either long or short, in SPRX or any of the other issues mentioned in your post. I am very interested, however, in diabetes management.